Loading clinical trials...
Loading clinical trials...
The goal of the study is to assess the prevalence of contrast-associated acute kidney injury in patients with stable coronary artery disease, ST-elevation myocardial infarction and unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury development and the influence of contrast-induced kidney injury on 1-year prognosis.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Sechenov University
Moscow, Russia
Start Date
January 15, 2019
Primary Completion Date
December 30, 2022
Completion Date
May 30, 2024
Last Updated
October 8, 2024
156
ACTUAL participants
Iodinated contrast
OTHER
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07444957